INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-2117176337-diversity]( "Analyzing The FDA's Approach To Diversity In Clinical Trials")
Analyzing The FDA's Approach To Diversity In Clinical TrialsLearn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
![450x300_ThinkUSA_v2]( "Think U.S.A.: The Operations Behind Your Clinical Trials")
Think U.S.A.: The Operations Behind Your Clinical TrialsReady to think differently about early-phase clinical development? Check out the spotlight on our U.S. clinical facilities and the incredible teams behind them.
-
![APAC - elderly woman gets help from her daughter with her cap (high res)]( "5 RWE Approaches That Strengthen Precision Oncology")
5 RWE Approaches That Strengthen Precision OncologyReal-world evidence is becoming vital in precision oncology. Discover five creative, practical ways sponsors can use RWE to fuel development, sharpen regulatory strategy, and strengthen market access.
-
![Patient Recruitment And Engagement]( "Smarter, More Accurate Patient Matching Enhances Trial Efficiency")
Smarter, More Accurate Patient Matching Enhances Trial EfficiencyEven when patient recruitment criteria grows complex, this direct-to-data approach can pinpoint precise patients needed and provide an alert to your team when they are found.
-
Applying AI to Study Simulation: From Design to Analysis5/12/2026
See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.
-
FDA Guidance On Payment And Reimbursement To Research Subjects12/5/2025
Learn how ethical, fair, and timely payment and reimbursement strategies can support participants, enhance trial accessibility, and uphold regulatory and IRB standards.
-
Health Economics And Outcomes Research (HEOR) Explained7/15/2025
Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.
-
Why Operational Design Determines Recruitment And Retention4/22/2026
Patient recruitment challenges often receive the most attention in clinical trials, yet many enrollment and retention issues stem from operational friction embedded in study design.
-
Data Privacy And Trust In China's Clinical Trials2/4/2026
China’s evolving privacy laws are reshaping how global trials operate. Sponsors that prioritize transparency and participant confidence can meet compliance demands while building lasting trust.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![iStock-187467661-quality-control-inspection]( "Navigating The Use Of Controlled Substances In Clinical Trials Using IRT")
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
-
![GettyImages-966826582 data, research, analytics]( "Drive Patient Enrollments With Data-Powered Recruitment Engine")
Generate consistent, successful clinical trial recruitment on repeat with Citeline Connect's multifaceted approach to patient engagement and recruitment.
-
![meeting]( "Get It Right The First Time: Strategic Clinical Development")
Start early and get it right the first time. Course correct with a changing landscape. Overcome obstacles within clinical development. Collaborate with the best strategists and problem-solvers in clinical development.
-
![GettyImages-1390000434 patients]( "Revolutionizing Engagement, Education, & Enrollment Across Clinical Portfolios")
Discover ways to amplify dialogue, trust, and participation around your clinical trials with Citeline’s end-to-end enterprise patient engagement and recruitment solution.
-
![GettyImages-904483784 doctor patient]( "Clinical Trial Site Selection And Management")
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
